[1]
Isabella Alvarez and Daniel Perez 2023. The Impact of GIP (Gastric Inhibitory Polypeptide) on the Development of Type 2 Diabetes in the Spanish Population: A Longitudinal Study. Sriwijaya Journal of Internal Medicine. 2, 1 (Nov. 2023), 25-36. DOI:https://doi.org/10.59345/sjim.v1i2.76.